Lonnel Coats
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Lonnel Coats
Earlier roles on record: CEO and Board Member at Lexicon Pharmaceuticals, Inc. (LXRX) until July 7, 2024. Lexicon Pharmaceuticals, Inc. reported in an 8-K filed April 29, 2024 that Lonnel Coats retired as member of our board of directors, effective July 7, 2024. Lexicon Pharmaceuticals, Inc. reported in an 8-K filed April 29, 2024 that Lonnel Coats retired as chief executive officer, effective July 7, 2024. The proxy statement of Lexicon Pharmaceuticals, Inc. reports total compensation of $3,512,773 for Lonnel Coats in fiscal 2024, including a base salary of $438,757. Disclosed compensation is on record for 8 fiscal years. Lonnel Coats has spoken on 16 earnings calls across 1 company, most recently for Lexicon Pharmaceuticals, Inc. on May 2, 2024.
“On April 24, 2024, Lonnel Coats notified us of his retirement as our chief executive officer (in which capacity, Mr. Coats functions as our principal executive officer) and as a member of our board of directors, in each case effective July 7, 2024.”
“On April 24, 2024, Lonnel Coats notified us of his retirement as our chief executive officer (in which capacity, Mr. Coats functions as our principal executive officer) and as a member of our board of directors, in each case effective July 7, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2024-07-07
-
Start not stated–2024-07-07
-
Start not stated–2024-07-07
-
Start not stated–2024-07-07
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Lexicon Pharmaceuticals, Inc. (LXRX) | Former Chief Executive Officer and Director | $438,757 | $3,512,773 |
| 2023 | Lexicon Pharmaceuticals, Inc. (LXRX) | Former Chief Executive Officer and Director | $740,846 | $4,110,121 |
| 2022 | Lexicon Pharmaceuticals, Inc. (LXRX) | Former Chief Executive Officer and Director | $709,637 | $4,169,942 |
| 2021 | Lexicon Pharmaceuticals, Inc. (LXRX) | Chief Executive Officer and Director | $688,825 | $3,924,090 |
| 2020 | Lexicon Pharmaceuticals, Inc. (LXRX) | Chief Executive Officer and Director | $668,620 | $3,860,671 |
| 2019 | Lexicon Pharmaceuticals, Inc. (LXRX) | Chief Executive Officer and Director | $649,196 | $3,870,291 |
| 2018 | Lexicon Pharmaceuticals, Inc. (LXRX) | President, Chief Executive Officer and Director | $634,159 | $3,123,433 |
| 2017 | Lexicon Pharmaceuticals, Inc. (LXRX) | President, Chief Executive Officer and Director | $618,259 | $2,212,187 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.